RXRX vs FRT-P-C

Comparison between Recursion Pharmaceuticals Inc - Class A (RXRX, Company) and Federal Realty Investment Trust. (FRT-P-C, Company).

5-Year PerformanceFRT-P-C has outperformed RXRX, delivering a return of -0.0% compared to -38.8%

RXRX vs FRT-P-C - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	RXRX(COMPANY)	FRT-P-C(COMPANY)
Market Cap	$1.76B	$1.76B
Max Drawdown	93.13%	30.45%
Sharpe Ratio	-0.61	-0.13
5Y Beta	2.63	0.23
Industry	Biotechnology	Other
P/E Ratio	-2.87	4.28
PEG Ratio	N/A	0.12
5Y Dividends CAGR	N/A	4.56%
5Y EPS CAGR	-10.03%	22.55%
Debt to Equity	0.00%	152.79%
Free Cash Flow Yield	-18.55%	35.40%
P/S Ratio	26.45	N/A
P/B Ratio	1.73	N/A

Market Cap

RXRX

$1.76B

Winner

FRT-P-C

$1.76B

Max Drawdown

RXRX

93.13%

Winner

FRT-P-C

30.45%

Sharpe Ratio

RXRX

-0.61

Winner

FRT-P-C

-0.13

5Y Beta

RXRX

2.63

Winner

FRT-P-C

0.23

Industry

RXRX

Biotechnology

FRT-P-C

Other

P/E Ratio

Winner

RXRX

-2.87

FRT-P-C

4.28

PEG Ratio

RXRX

N/A

FRT-P-C

0.12

5Y Dividends CAGR

RXRX

N/A

FRT-P-C

4.56%

5Y EPS CAGR

RXRX

-10.03%

Winner

FRT-P-C

22.55%

Debt to Equity

Winner

RXRX

0.00%

FRT-P-C

152.79%

Free Cash Flow Yield

RXRX

-18.55%

Winner

FRT-P-C

35.40%

P/S Ratio

RXRX

26.45

FRT-P-C

N/A

P/B Ratio

RXRX

1.73

FRT-P-C

N/A

RXRX vs FRT-P-C - Historical Returns

Returns include dividend reinvestment.

Period	RXRX	FRT-P-C
1 month	-3.14%	-0.17%
3 months	-13.48%	+2.50%
6 months	-33.19%	-0.07%
1 year	-51.88%	+2.06%
5 years(CAGR)	-38.84%	-0.03%
10 years(CAGR)	N/A	+2.61%
Max(CAGR)	-35.64%	+2.61%

RXRX

-3.14%

Winner

FRT-P-C

-0.17%

RXRX

-13.48%

Winner

FRT-P-C

+2.50%

RXRX

-33.19%

Winner

FRT-P-C

-0.07%

RXRX

-51.88%

Winner

FRT-P-C

+2.06%

5Y(CAGR)

RXRX

-38.84%

Winner

FRT-P-C

-0.03%

10Y(CAGR)

RXRX

N/A

FRT-P-C

+2.61%

Max(CAGR)

RXRX

-35.64%

Winner

FRT-P-C

+2.61%

RXRX vs FRT-P-C - Annual Returns (2017 - 2026)

Returns include dividend reinvestment.

Year	RXRX	FRT-P-C
2026	-26.67%	+0.63%
2025	-43.27%	-2.16%
2024	-31.51%	-1.76%
2023	+30.60%	+16.50%
2022	-57.24%	-16.34%
2021	-45.27%	+3.95%
2020	N/A	+4.48%
2019	N/A	+28.40%
2018	N/A	-11.86%
2017	N/A	+1.93%

RXRX vs FRT-P-C Drawdown Comparison

The maximum drawdown for RXRX was -93.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The maximum drawdown for FRT-P-C was -28.33%, occurring on Mar 23, 2020. Recovery took 121 trading sessions.

The current RXRX drawdown is -92.55%. The current FRT-P-C drawdown is -6.69%.

Rank	RXRX	FRT-P-C
#1	-93.13% Jul 13, 2021 - Mar 30, 2026	-28.33% Feb 18, 2020 - Aug 10, 2020
#2	-38.10% Apr 29, 2021 - Jun 17, 2021	-24.15% Aug 3, 2022 - Jan 30, 2024
#3	-10.54% Apr 16, 2021 - Apr 21, 2021	-15.21% Jun 18, 2018 - Feb 5, 2019
#4	-10.45% Jun 21, 2021 - Jul 6, 2021	-13.81% Dec 29, 2017 - Jun 18, 2018
#5	-8.29% Apr 21, 2021 - Apr 29, 2021	-12.96% Oct 18, 2024 - Apr 7, 2025
#6	N/A	-12.59% Jan 30, 2024 - Sep 20, 2024
#7	N/A	-10.87% Jul 7, 2021 - Jul 29, 2022
#8	N/A	-6.00% Oct 7, 2020 - Apr 1, 2021
#9	N/A	-5.25% Feb 6, 2019 - Apr 3, 2019
#10	N/A	-3.67% Oct 23, 2019 - Jan 2, 2020
#11	N/A	-3.54% Apr 13, 2021 - Jul 7, 2021
#12	N/A	-2.80% Sep 26, 2017 - Dec 15, 2017
#13	N/A	-2.54% Aug 18, 2020 - Sep 15, 2020
#14	N/A	-2.32% Sep 22, 2020 - Sep 28, 2020
#15	N/A	-1.96% Sep 4, 2019 - Oct 11, 2019